Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair loss causes stress and affects mental health; treatment and support needed.

Hair stops producing melanin as it transitions from the growth phase to the resting phase.

Estrogen affects hair growth and skin cell multiplication.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Hair shedding is an active process that could be targeted to treat hair loss.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document says there are five types of hair loss conditions and different causes, including drugs.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Wnt signaling is important for the change from the resting phase to the growth phase in human hair cycles.

The dietary supplement helped increase hair growth in women with hair loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

COVID-19 may cause hair loss due to infection stress or treatments.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

Estrogen can temporarily slow down hair growth but this can be reversed.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.